Moderna sketches out 94.1% efficacy for COVID-19 vax based on more cases, with EUA plotted for today CVS Caremark chief: The biggest challenges in distributing a COVID-19 vaccine Signed, sealed, delivered: Pfizer marks first 'mass air shipment' of COVID-19 shot amid cold-chain scrutiny Sponsored: Predicting Landfall: A Dynamic Control Room for Taking on the COVID-19 Landscape AstraZeneca staffers targeted in suspected hacking scheme amid work on COVID-19 vaccine: report KFF: More than 100K died in nursing homes, long-term care facilities from COVID-19 AstraZeneca nears temporary OK for COVID-19 vaccine, plots extra trial Hospital operating margins down nearly 20% since start of year due to COVID-19, report says Novavax, swamped with FDA's manufacturing 'questions,' hopes for US coronavirus shot trial within the year Healthcare roundup: California requires hospitals to test staff, patients for COVID-19 Biopharma roundup: Novavax's US trial start stalls amid FDA questions; Pfizer OK could come 'within days' of review: Azar Featured Story | By Ben Adams As Moderna continues to drip-feed the latest data from its late-stage COVID-19 vaccine effort, it has updated the shot’s efficacy figure. read more |
| |
|---|
|
Top Stories By Paige Minemyer With the distribution of a COVID-19 vaccine looming, companies in the pharmaceutical supply chain are working overtime to plan for all contingencies. read more By Fraiser Kansteiner Pfizer, alone among its peers, has faced fever-pitch scrutiny over the stringent cold storage requirements for its COVID-19 vaccine—and the logistical challenges that could pose. Looking to ease the doubters' concerns, Pfizer has now shipped its first doses by air to the U.S., and distributors are watching closely. read more Sponsored by: Syneos Health When it comes to COVID-19 commercialization, multiple disrupters are likely to impact an asset’s trajectory. Gain the real-time perspective needed to pivot fast in an ever changing environment. read more By Angus Liu Some AstraZeneca staffers may have thought they were talking to corporate recruiters on LinkedIn and WhatsApp, but these job offers were merely fabricated by North Korean hackers as part of a scheme to breach its computer systems and steal COVID-related research, Reuters reported. read more By Robert King More than 100,000 residents and staff in nursing homes and long-term care facilities have died from COVID-19 as another surge approaches, a new analysis finds. read more By Nick Paul Taylor The U.K. government has asked the national regulator to consider clearing AstraZeneca’s COVID-19 vaccine for temporary supply as soon as it receives safety, quality and efficacy data. Requesting use of the fast track positions the U.K. to be among the first countries to begin a COVID-19 vaccination campaign. read more By Robert King Hospital and health systems saw their operating margins decline by nearly 20% since the start of 2020 due to the pandemic as the virus starts to surge again, Kaufman Hall reported. read more By Kyle Blankenship With two players in the race for a COVID-19 vaccine nearing the finish line on world-first regulatory approvals, Maryland biotech Novavax continues to lag behind in getting its candidate into a late-stage trial in the U.S. Now, that trial has been pushed back further as the FDA targets its manufacturing plans. read more By Healthcare Staff Follow along with the latest COVID-19 news straight from the Fierce Healthcare team. read more Novavax's phase 3 U.S. shot trial has been pushed back over manufacturing questions. Pfizer is trialing its distribution scheme ahead of authorization. Kantaro won an emergency nod for its antibody test. Plus, Northwestern researchers developed an AI algorithm to detect signs of COVID-19 via X-ray. read more |
